M Iacobone, G Viel, S Zanella, M Frego, G Favia

Slides:



Advertisements
Similar presentations
At the Clinic Scenario: Endocrine System
Advertisements

Addison’s, Cushing’s & Acromegaly
Adrenal Dr Sohail Inam FRCP(Ed), FRCP Consultant Endocrinologist
Determining the type of Cushing’s syndrome: Not as hard as it seems Theodore C. Friedman, M.D., Ph.D. Professor of Medicine-Charles Drew University Professor.
Clinical case 2003… A 30 year-old woman…...admitted to our hospital due to obesity and diabetes mellitus...
Adrenal Incidentaloma: An Update of its Management 18 th September 2004 Dominic Tai Division of Urology Department of Surgery Pamela Youde Nethersole Eastern.
Primary Aldosteronism: an update on the management
Factors associated with prediabetes in adult children of patients with premature coronary heart disease; the study of families of patients with premature.
Adrenal Gland.
Cushing’s Syndrome Britni Hebert PGY 2 4/9/10 Notes located in presenter note section below each slide.
ADRENAL CORTEX CUSHING, CONN AND ADDISON DISEASE CUSHING, CONN AND ADDISON DISEASE Snježana Vukelić Mentor: A. Žmegač Horvat.
Adrenal gland. ? What is the adrenal gland The adrenal glands (also known as suprarenal glands) are the triangle-shaped and orange- colored endocrine.
 Located above the kidneys like a hat for them.
Adrenal Glands  Learning objectives:  The student should:  Recognize the variants of hyperadrenalism  Recognize the variants of hypoadrenalism  Understand.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
Adrenal Masses: Differential Dx and Work-up Sara Faber August 4, 2008.
Endocrine System. SymptomsTreatmentTestsGeneral info Recommendation
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Secondary Hypertension: Adrenal and Nervous Systems Ανδρέας Πιτταράς Καρδιολόγος Καρδιολόγος Clinical Hypertension Specialist ESH Υπερτασικό ιατρείο Τζάνειο.
Cushing’s syndrome 一40岁女性,自述近两年体重增加,尤其腹部,但体力却明显下降。到当地医院就诊时发现血压高、血糖高、血脂高、血钾低,对症治疗不见好转来诊。你考虑该患可能得了什么病?线索?为什么?还应做那些检查? 鉴别:2型糖尿病:类固醇性糖尿病:小剂量地塞米松抑制试验被抑制 代谢综合征:
Blood pressure control in primary health care WORKSHOP
Beyond pituitary surgery: Radiosurgery vs. Adrenalectomy vs Medical Treatment when Cushing’s disease persists or recurs Theodore C. Friedman, M.D., Ph.D.
Hypercortisolism (Cushing’ s Syndrome)
 Learning objectives:  The student should:  Recognize the variants of hyperadrenalism  Recognize the variants of hypoadrenalism  Understand the histopathological.
Adult Medical-Surgical Nursing Endocrine Module: Disorders of the Adrenal Cortex: Cushing’s Syndrome.
Cushing’s Syndrome.
Check your knowledge in… Adrenal diseases. Which treatment is indicated in case of hyperaldosteronism due to adrenal hyperplasia? 1.Medical treatment.
Adult Medical-Surgical Nursing Endocrine Module: Anterior Pituitary Hypersecretion (ACTH)
Human Physiology Endocrine Glands Chapter 8. Hypothalamus and Pituitary A 50 year-old and has a pituitary tumor that produces excess amounts of growth.
Case 1 49 yo male with hypertension on a potassium-sparing diuretic.
This lecture was conducted during the Nephrology Unit Grand Ground by Registrar under Nephrology Division under the supervision and administration of Prof.
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
ENDOCRINE DISORDERS AND DIABETES MELLITUS Prof. Dr. Jan Škrha 3rd Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Armed Forces Academy of Medical Sciences
INVESTIGATION OF GLUCOCORTICOID EXCESS Dr. Umar M.T.
Armed Forces Academy of Medical Sciences
+ This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Cushing’s syndrome. Most common cause of Cushing’s syndrome?
Evaluation and Management of the Patient with Hypertension and Hypokalemia Stephen L. Aronoff, MD.
DISORDERS OF THE ADRENOCORTICAL HORMONES Dr. Ayisha Qureshi MBBS, Mphil.
Cushing’s syndrome Zhaoxiaojuan. Effects of glucocorticoid Effects on metabolism Effects on immunologic function and inflammatory Effects on musculoskeletal.
Cushing’s Syndrome Hasan AYDIN, M.D. Endocrinology and Metabolism
Cushing's syndrome Abdullah Alhowidi Definition Cushing's syndrome is a characteristic group of manifestations caused by excessive circulating.
BYBY. History  Female patient 6 yrs old with a history of progressive weight gain and increasing hair growth of 3 months duration.  History of polyphagia,
Case Presentation LM – 11/2011. Presenting Complaint Current age - 3 Yr 11 mth ♀ Premature pubarche First noticed between 18 mth and 2yr Progressive.
Zona Glomerulosa Zona Fasiculata Zona Reticularis.
The cortex consists of 3 layers 1 st is zona granulosa - mineralocorticoids, for example aldosterone. The inner 2 layers are zona fasiculata and zona reticularis.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
내분비대사내과 R3 박유민 /Prof 이상열 MGR review.  Cushing's syndrome reflects a constellation of clinical features that result from chronic exposure to.
Resistant Hypertension - Primary Aldosteronism - 내분비 대사 내과 R3 송 란.
Date of download: 9/18/2016 From: “Nonfunctional” Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study Ann Intern.
Assistant lecturer of Pediatrics
Radiology and Endocrinology
This PowerPoint document contains the images that you requested.
Pertinent Laboratory Data
From ESH 2016 | POS 7D: Jan Rosa, MD
Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin
Acromegalic cardiomyopathy: A case report
A Multidisciplinary Team Approach Challenges and Best Practices in Cushing Disease.
Disorders of the Adrenal Gland
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Use of Mifepristone for Prevention of Adrenal Insufficiency Following
© The Author(s) Published by Science and Education Publishing.
Theodore C. Friedman, M.D., Ph.D. Symposium on Cushing’s Syndrome
Major Hormone Secreting Glands of the Endocrine System
WM Yu (1), SS Lo (1), CS Chan (1), SM Yu (1), HC Lee (1) 
Determining the type of Cushing’s syndrome: Not as hard as it seems
Presentation transcript:

M Iacobone, G Viel, S Zanella, M Frego, G Favia THE ROLE OF UNILATERAL ADRENALECTOMY IN ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA (AIMAH) M Iacobone, G Viel, S Zanella, M Frego, G Favia Department of Endocrine Surgery University of Padua, Italy

- ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH) Cushing’s Syndrome ACTH dependent (80%) Pituitary Ectopic ACTH independent (20%) Unilateral (Adenoma, Carcinoma) Bilateral - PPNAD - ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH)

ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH) Slowly Progressing Disease Mild Hypercortisolism Bilateral Macronodules Ectopic Receptors (GIP, Catecholamines, LH/hCG)

Bilateral Adrenalectomy Partial adrenalectomies AIMAH - Therapy Lifetime steroid replacement Bilateral Adrenalectomy Octreotide Propanolol Leuprolide Medical Treatment Ectopic Receptors Subtotal Unilateral Partial adrenalectomies

of Unilateral Adrenalectomy for AIMAH AIM of the STUDY Long-term results of Unilateral Adrenalectomy for AIMAH

PATIENTS and METHODS (1) Jan 01-Dec 05 Unilateral Adrenalectomy and AIMAH (n=7) Males: 2 ; Females: 5 Age: 55 yr (36 – 71) DIAGNOSIS: Clinical, Laboratory, Imaging, Pathology Cushing’s Syndrome

CT/MRI + I-131 norcholesterol Scintigraphy PATIENTS ET METHODS (2) CT/MRI + I-131 norcholesterol Scintigraphy Asymmetric involvement Unilateral adrenalectomy

Glycometabolic Parameters Body Mass Index (BMI) PATIENTS ET METHODS (3) Serum ACTH and Cortisol UFC Circadian rhythm DMX suppression test Hormonal Parameters Blood Pressure Glycometabolic Parameters Body Mass Index (BMI) Subjective Perception of Quality of Life (SF-36: MCS + PCS) OGTT HbA1c

CURE: 86% Persistent hypercortisolism: 1 case RESULTS (1) Morbidity: 0% CURE: 86% Persistent hypercortisolism: 1 case Completion contralateral adrenalectomy Large contralateral remaining adrenal Symmetric uptake at scintigraphy

Normal range CURE: 6 PATIENTS RESULTS (2) Follow-up: 53 months (range 27-68) CURE: 6 PATIENTS HORMONAL PARAMETERS Normal range Serum ACTH Serum Cortisol Urinary free Cortisol Normal Circadian rhythm Normal DMX suppression test

CURE: 6 PATIENTS RESULTS (2) Follow-up: 53 months (range 27-68) “Small” contralateral remaining adrenal Asymmetric uptake at scintigraphy

HORMONAL PARAMETERS RESULTS (3) ACTH UFC 0,006 0,04 ACTH PRE-OP POST-OP p ACTH (nv 10-50 ng/L) 7 + 2 28 + 11 0,006 Urinary Free Cortisol (nv 28-214 nmol/day) 1206 + 1038 59 + 16 0,04 ACTH UFC

HYPERTENSION RESULTS (4) 0,006 0,001 RECOVERY: 50% DRUG REDUCTION: 50% BLOOD PRESSURE PRE-OP POST-OP p Systolic BP (mmHg) 152 + 15 130 + 8 0,006 Diastolic BP (mmHg) 92 + 5 79 + 4 0,001 HYPERTENSION RECOVERY: 50% DRUG REDUCTION: 50%

DIABETES 0,005 0,002 RESULTS (5) OGTT (nv <7.1 mmol/L) GLUCOSE METABOLISM PRE-OP POST-OP p OGTT (nv <7.1 mmol/L) 8.6 + 2 6.7 + 1 0,005 HbA1c (nv 3,7–6,1%) 7.4 + 1% 5.8 + 1% 0,002 DIABETES RECOVERY: 40% DRUG REDUCTION: 40%

RESULTS (6) BMI (nv<25 kg/mq) 0,03 BODY MASS INDEX PRE-OP POST-OP p BMI (nv<25 kg/mq) 28,7 + 5 25,8 + 3,5 0,03

Physical Component Summary RESULTS (7) SF-36 QUALITY OF LIFE * * * p<0,01 Physical Component Summary Mental Component Summary

(case selection) Unilateral adrenalectomy EFFECTIVE TREATMENT CONCLUSIONS (1) AIMAH Asymmetric adrenal involvement “Small” remaining gland (case selection) Unilateral adrenalectomy EFFECTIVE TREATMENT

Postoperative adrenal insufficiency Table 3. Literature review: unilateral adrenalectomy for AIMAH.   Author Number of cases Follow-up (months) Postoperative adrenal insufficiency (length) Outcome Lamas [9] 4 74 (range 30-137) 2 cases (60 and 14 months) Cure of CS (4 cases) ·   Normalization of serum cortisol, UFC and ACTH ·   Abnormal circadian cortisol rhythm ·   Abnormal responsiveness to dexamethasone suppression test ·   No enlargement of the remaining gland Vezzosi [12] 1 7 1 case (6 months) Cure of CS ·   Normalization of UFC, serum cortisol ·   Normal responsiveness to dexamethasone suppression test Lacroix [2, 6] 36 (15 months) ·   Subnormal ACTH Sato [13] 8 (8 months) ·   Subnormal serum cortisol and UFC Ogura [11] 24 - ·   Normal ACTH, serum cortisol ·   Normal circadian cortisol rhythm ·   Subnormal UFC ·   Unchanged BMI and BP ·   Improvement of glycemic control Imohl [10] 27 ·   Normalization of serum cortisol and circadian cortisol rhythm N’Diaye [7] 12 1 cases (12 months) ·   Subnormal, serum cortisol and UFC ·   Mild enlargement (3 mm) of the remaining gland Doppmann [8] 64 Present series (WJS 2008) 53 (range 7-68) (7 and 24 months) Persistent CS (1 case)   C Cure of CS (6 cases) ·   Normalization of ACTH, serum cortisol, circadian cortisol rhythm and UFC ·   Improvement of BP, glycemic control and BMI  

Unilateral adrenalectomy for AIMAH CONCLUSIONS (2) Unilateral adrenalectomy for AIMAH Cure of hypercortisolism BP improvement BMI decrease Glycemic control improvement Quality of life improvement